| Patent Number |
Title Of Patent |
Date Issued |
| 7402305 |
Polypeptides of the IFN.alpha.-21 gene |
July 22, 2008 |
| Polynucleotides and polypeptides derived from the nucleotide sequence of the IFN.alpha.-21 gene comprising SNPs, and their therapeutic uses. |
| 7399464 |
Polypeptides of the IFN.alpha.-7 gene |
July 15, 2008 |
| The present invention relates to new polynucleotides derived from the nucleotide sequence of the IFN.alpha.-7 gene comprising new SNPs, and new polypeptides derived from the wild-type IFN.alpha.-7 protein comprising at least one mutation caused by at least one SNP of the invention as wel |
| 7371819 |
Polypeptides of the IFN.alpha.-17 gene |
May 13, 2008 |
| The present invention relates to new polynucleotides derived from the nucleotide sequence of the IFN.alpha.-17 gene comprising new SNPs, and new polypeptides derived from the natural wild-type IFN.alpha.-17 protein comprising at least one mutation caused by at least one SNP of the in |
| 7358333 |
Polypeptides of the IFN.alpha.-5 gene |
April 15, 2008 |
| The present invention relates to new polynucleotides derived from the nucleotide sequence of the IFN.alpha.-5 gene comprising new SNPs, and new polypeptides derived from the natural wild-type IFN.alpha.-5 protein comprising at least one mutation caused by at least one SNP of the inve |
| 7041794 |
Polynucleotides and polypeptides of the erythropoietin gene |
May 9, 2006 |
| The present invention relates to new polynucleotides deriving from the nucleotide sequence of the EPO gene and comprising new SNPs, new polypeptides derived from the natural EPO protein and comprising at least one mutation caused by the SNPs of the invention as well as their therapeu |
